# Study to Characterize the Effect of Heparin on Palifermin Activity

> **NCT01163097** · PHASE1 · COMPLETED · sponsor: **Swedish Orphan Biovitrum** · enrollment: 44 (actual)

## Conditions studied

- Oral Mucositis

## Interventions

- **DRUG:** Palifermin
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT01163097
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2014-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01163097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01163097, "Study to Characterize the Effect of Heparin on Palifermin Activity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01163097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*